Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(3.4%),Lind Global Partners II LLC(3.4%), etc.
Intelligent Bio Solutions | SC 13G: Statement of acquisition of beneficial ownership by individuals-Alyeska Investment Group, L.P.(9.99%),Alyeska Fund GP, LLC(9.99%), etc.
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
Intelligent Bio Solutions | 10-Q: Q1 2025 Earnings Report
Intelligent Bio Solutions | 8-K: Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Sakiris Spiro Kevin
Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Simeonidis Harry
Intelligent Bio Solutions | 8-K: Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 424B5: Prospectus
Intelligent Bio Solutions | 10-K: FY2024 Annual Report
Intelligent Bio Solutions | 8-K: Current report
Intelligent Bio Solutions | 8-K: Current report
No Data